SCHEMBL21888879

SCHEMBL21888879

C=C(C)C(=O)OCCCOc1ccc(-c2ccc(C(=O)c3ccc(-c4ccc(OCCCOC(=O)C(=C)C)cc4)cc3C)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.57
▸ POLB P06746 1/20 0.57
▸ APEX1 P27695 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PPARD Q03181 2/20 0.40
▸ PPARG P37231 1/20 0.40
▸ PPARA Q07869 1/20 0.40
▸ RARB P10826 6/20 0.40
▸ GAA P10253 2/20 0.40
▸ RARA P10276 1/20 0.39
▸ ELANE P08246 1/20 0.39
▸ HRH2 P25021 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ SRD5A2 P31213 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ GSTP1 P09211 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21889797 0.88 HTT (0.68) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL17190954 0.84 POLB (0.54) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL21889396 0.83 HTT (0.62) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL21888887 0.83 POLB (0.56) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL21888880 0.81 TDP1 (0.56) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL14400544 0.81 HTT (0.73) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL14540216 0.80 HTT (0.52) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL21889394 0.80 POLB (0.58) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL15084291 0.80 HTT (0.81) HTTPOLBAPEX1TDP1L3MBTL1
SCHEMBL16982216 0.79 HTT (0.76) HTTPOLBAPEX1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954183-B2 Curable composition, semi-cured product, cured product, optical member, lens, and compound FUJIFILM CORPORATION (JP) 2021-03-23 — — US disclosed
US-20200115316-A1 CURABLE COMPOSITION, SEMI-CURED PRODUCT, CURED PRODUCT, OPTICAL MEMBER, LENS, AND COMPOUND FUJIFILM CORPORATION (JP) 2020-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115316-A1 CURABLE COMPOSITION, SEMI-CURED PRODUCT, CURED PRODUCT, OPTICAL MEMBER, LENS, AND COMPOUND CRYAA, Q6ZSR9, CRYZ HTT 698/4885POLB 3686/4885APEX1 4544/4885
US-10954183-B2 Curable composition, semi-cured product, cured product, optical member, lens, and compound CRYAA, Q6ZSR9, CRYZ HTT 698/4885POLB 3686/4885APEX1 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback